All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
TSRO / TESARO, Inc.
|
|
|
|
|
|
|
|
YMTX / Yumanity Therapeutics Inc
|
|
|
|
|
|
|
|
SBBP / Strongbridge Biopharma plc
|
|
|
|
|
|
|
|
CASC / Cascadian Therapeutics, Inc.
|
|
|
|
|
|
|
|
TNTR / Tintri, Inc.
|
|
|
|
|
|
|
|
OREX / Orexigen Therapeutics, Inc.
|
|
|
|
|
|
|
|
US29266S3040 / Endologix, Inc.
|
|
|
|
|
|
|
|
ARQL / ArQule, Inc.
|
|
|
|
|
|
|
|
EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
|
|
|
|
|
SCMP / Sucampo Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CRCM / Care.com, Inc.
|
|
|
|
|
|
|
|
/ Achaogen Inc
|
|
|
|
|
|
|
|
007786106 / Aerohive Networks, Inc.
|
|
|
|
|
|
|
|
SNAP / Snap Inc.
|
|
|
|
|
|
|
|
ROKA / Roka Bioscience, Inc.
|
|
|
|
|
|
|
|
GRPN / Groupon, Inc.
|
|
|
|
|
|
|
|
ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
DZSI / DZS Inc.
|
|
|
|
|
|
|
|
CBIO / Crescent Biopharma, Inc.
|
|
|
|
|
|
|
|
PRTK / Paratek Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
RARX / Ra Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SENS / Senseonics Holdings, Inc.
|
|
|
|
|
|
|
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
TRVN / Trevena, Inc.
|
|
|
|
|
|
|
|
SYBX / Synlogic, Inc.
|
|
|
|
|
|
|
|
AVTX / Avalo Therapeutics, Inc.
|
|
|
|
|
|
|
|
AVEO / AVEO Pharmaceuticals Inc
|
|
|
|
|
|
|
|
LXRX / Lexicon Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
TRIL / Trillium Therapeutics Inc
|
|
|
|
|
|
|
|
OBSV / ObsEva SA.
|
|
|
|
|
|
|
|
MRSN / Mersana Therapeutics, Inc.
|
|
|
|
|
|
|
|
NVRO / Nevro Corp.
|
|
|
|
|
|
|
|
TCON / TRACON Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ABIO / ARCA biopharma, Inc.
|
|
|
|
|
|
|
|
AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
CSBR / Champions Oncology, Inc.
|
|
|
|
|
|
|
|
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
GLYC / GlycoMimetics, Inc.
|
|
|
|
|
|
|
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CRSP / CRISPR Therapeutics AG
|
|
|
|
|
|
|
|